EyePoint Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US30233G2093

SecurityEYPT / EyePoint Pharmaceuticals, Inc.
InsiderNancy Lurker
This page shows the track record and history of Lurker Nancy insider trades in EyePoint Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Nancy Lurker in EYPT / EyePoint Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-08-16 3,173 7.8800 3,173 7.8800 25,003 73 12.1200 13,454 53.81
2020-03-10 98,000 1.0615 9,800 10.6150 104,027
2019-03-29 28,500 1.7630 2,850 17.6300 50,246
2017-06-14 56,700 1.7630 56,700 1.7630 99,962

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EYPT / EyePoint Pharmaceuticals, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Nancy Lurker in EYPT / EyePoint Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-01-24 29,956 24.9783 29,956 24.9783 748,250 341 7.0200 -537,958 -71.90
2024-01-23 5,044 24.9702 5,044 24.9702 125,950
2023-12-04 20,000 20.7600 20,000 20.7600 415,200

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EYPT / EyePoint Pharmaceuticals, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-07-11 2025-07-10 4 Lurker Nancy EYPT Common Stock M - Exercise D 11,111 216,547
2025-02-11 2025-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 20,000 205,436
2025-01-07 2025-01-06 4 Lurker Nancy EYPT Common Stock M - Exercise D 75,134 185,436
2025-01-07 2025-01-05 4 Lurker Nancy EYPT Common Stock M - Exercise D 12,667 110,302
2024-08-20 2024-08-16 4 Lurker Nancy EYPT Common Stock P - Purchase D 7.8800 3,173 25 97,635
2024-07-12 2024-07-10 4 Lurker Nancy EYPT Common Stock M - Exercise D 11,111 94,462
2024-02-13 2024-02-13 4 Lurker Nancy By Family Trust EYPT Common Stock G - Gift I 74,681 126,889
2024-02-13 2024-02-13 4 Lurker Nancy EYPT Common Stock G - Gift D -74,681 83,351
2024-02-13 2024-02-09 4 Lurker Nancy EYPT Common Stock F - Taxes D 28.8000 -6,981 -201 158,032
2024-02-13 2024-02-09 4 Lurker Nancy EYPT Common Stock F - Taxes D 28.8000 -7,962 -229 165,013
2024-02-13 2024-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 17,534 172,975
2024-02-13 2024-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 20,000 155,441
2024-01-25 2024-01-24 4 Lurker Nancy EYPT Common Stock S - Sale D 24.9783 -29,956 -748 135,441
2024-01-25 2024-01-23 4 Lurker Nancy EYPT Common Stock S - Sale D 24.9702 -5,044 -126 165,397
2024-01-09 2024-01-06 4 Lurker Nancy EYPT Common Stock F - Taxes D 20.4000 -23,043 -470 170,441
2024-01-09 2024-01-06 4 Lurker Nancy EYPT Common Stock M - Exercise D 75,133 193,484
2024-01-03 2023-12-28 4/A Lurker Nancy By Family Trust EYPT Common Stock G - Gift I 52,208 52,208
2024-01-03 2023-12-28 4/A Lurker Nancy EYPT Common Stock G - Gift D -52,208 118,351
2023-12-06 2023-12-04 4 Lurker Nancy EYPT Common Stock S - Sale D 20.7600 -20,000 -415 170,559
2023-02-13 2023-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 20,000 190,559
2023-02-13 2023-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 17,533 170,559
2022-03-02 2022-02-28 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -12,466 0
2022-03-02 2022-02-28 4 Lurker Nancy EYPT Common Stock M - Exercise D 12,466 150,281
2022-02-23 2022-02-21 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -13,717 13,718
2022-02-23 2022-02-21 4 Lurker Nancy EYPT Common Stock M - Exercise D 13,717 137,815
2022-02-11 2022-02-09 4 Lurker Nancy EYPT Stock Option (Right to Buy) A - Award D 10.13 240,000 240,000
2022-02-11 2022-02-09 4 Lurker Nancy EYPT Restricted Stock Units A - Award D 0.00 60,000 60,000
2022-02-11 2022-02-09 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -17,533 35,067
2022-02-11 2022-02-09 4 Lurker Nancy EYPT Common Stock M - Exercise D 17,533 124,098
2021-11-17 2021-11-15 4 Lurker Nancy EYPT Common Stock S - Sale D 20.1480 -10,000 -201 103,546
2021-06-23 2021-06-22 4 Lurker Nancy EYPT Stock Option (Right to Buy) A - Award D 13.13 213,700 213,700
2021-06-23 2021-06-22 4 Lurker Nancy EYPT Restricted Stock Units A - Award D 0.00 52,600 52,600
2021-06-15 2021-06-14 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -4,500 0
2021-06-15 2021-06-14 4 Lurker Nancy EYPT Common Stock M - Exercise D 4,500 113,546
2021-03-02 2021-02-28 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -12,467 12,466
2021-03-02 2021-02-28 4 Lurker Nancy EYPT Common Stock M - Exercise D 12,467 109,046
2021-02-23 2021-02-21 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -13,717 13,718
2021-02-23 2021-02-21 4 Lurker Nancy EYPT Common Stock M - Exercise D 13,717 96,579
2021-02-11 2020-06-15 5 Lurker Nancy By Family Trust EYPT Stock Option (Right to Buy) G - Gift I 26.50 27,132 27,132
2021-02-11 2020-06-15 5 Lurker Nancy EYPT Stock Option (Right to Buy) G - Gift D 26.50 -27,132 65,868
2021-02-11 2020-06-15 5 Lurker Nancy By Family Trust EYPT Stock Option (Right to Buy) G - Gift I 20.40 18,000 18,000
2021-02-11 2020-06-15 5 Lurker Nancy EYPT Stock Option (Right to Buy) G - Gift D 20.40 -18,000 36,000
2021-02-11 2020-06-15 5 Lurker Nancy By Family Trust EYPT Stock Option (Right to Buy) G - Gift I 17.70 16,000 16,000
2021-02-11 2020-06-15 5 Lurker Nancy EYPT Stock Option (Right to Buy) G - Gift D 17.70 -16,000 8,000
2021-02-11 2020-06-15 5 Lurker Nancy By Family Trust EYPT Stock Option (Right to Buy) G - Gift I 36.30 63,750 63,750
2021-02-11 2020-06-15 5 Lurker Nancy EYPT Stock Option (Right to Buy) G - Gift D 36.30 -63,750 21,250
2020-07-02 2020-06-30 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -124,667 249,333
2020-07-02 2020-06-30 4 Lurker Nancy EYPT Common Stock M - Exercise D 124,667 784,467
2020-06-30 2020-06-27 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -40,000 0
2020-06-30 2020-06-27 4 Lurker Nancy EYPT Common Stock M - Exercise D 40,000 659,800
2020-06-16 2020-06-14 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -45,000 45,000
2020-06-16 2020-06-14 4 Lurker Nancy EYPT Common Stock M - Exercise D 45,000 619,800
2020-03-11 2020-03-10 4 Lurker Nancy EYPT Common Stock P - Purchase D 1.0615 98,000 104 574,800
2020-03-03 2020-02-28 4 Lurker Nancy EYPT Stock Option (Right to Buy) A - Award D 1.29 748,000 748,000
2020-03-03 2020-02-28 4 Lurker Nancy EYPT Restricted Stock Units A - Award D 0.00 374,000 374,000
2020-02-25 2020-02-21 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -137,174 274,349
2020-02-25 2020-02-21 4 Lurker Nancy EYPT Common Stock M - Exercise D 137,174 476,800
2019-10-15 2019-10-12 4 Lurker Nancy EYPT Common Stock F - Taxes D 2.1050 -10,745 -23 314,455
2019-06-28 2019-06-27 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -40,000 40,000
2019-06-28 2019-06-27 4 Lurker Nancy EYPT Common Stock M - Exercise D 40,000 325,200
2019-06-27 2019-06-25 4 Lurker Nancy EYPT Stock Option (Right to Buy) A - Award D 2.65 930,000 930,000
2019-06-27 2019-06-25 4 Lurker Nancy EYPT Restricted Stock Units A - Award D 0.00 411,523 411,523
2019-06-17 2019-06-14 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D 0.00 -45,000 90,000
2019-06-17 2019-06-14 4 Lurker Nancy EYPT Common Stock M - Exercise D 45,000 285,200
2019-04-01 2019-03-29 4 Lurker Nancy EYPT Common Stock P - Purchase D 1.7630 28,500 50 240,200
2018-10-16 2018-10-12 4 Lurker Nancy EYPT Common Stock A - Award D 76,667 211,700
2018-06-29 2018-06-27 4 Lurker Nancy EYPT Restricted Stock Units M - Exercise D -40,000 80,000
2018-06-29 2018-06-27 4 Lurker Nancy EYPT Common Stock M - Exercise D 40,000 135,033
2018-06-18 2018-06-14 4 Lurker Nancy EYPT Stock Option (right to buy) A - Award D 2.04 540,000 540,000
2018-06-18 2018-06-14 4 Lurker Nancy EYPT Restricted Stock Units A - Award D 135,000 135,000
2018-03-21 2018-03-19 4 Lurker Nancy PSDV Common stock A - Award D 38,333 95,033
2017-12-19 2017-12-15 4 Lurker Nancy PSDV Stock Option (right to buy) A - Award D 1.77 240,000 240,000
2017-12-19 2017-12-15 4 Lurker Nancy PSDV Restricted Stock Units A - Award D 120,000 120,000
2017-06-14 2017-06-14 4 Lurker Nancy PSDV Common Stock P - Purchase D 1.7630 56,700 100 56,700
2016-12-14 2016-12-12 4 Lurker Nancy PSDV Employee Stock Option (right to buy) A - Award D 3.63 850,000 850,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)